All tenders
75A50126C00004
LATE-STAGE DEVELOPMENT, FDA MARKETING AUTHORIZATION, PROCUREMENT, AND STOCKPILE OF ANTIBIOTICS FOR THE TREATMENT OF DRUG-RESISTANT SECONDARY BACTERIAL INFECTIONS AND/OR THE TREATMENT OR PEP OF INFECTIONS CAUSED BY BIOTHREAT PATHOGENS.
Department of Health and Human Services · NJ, United States
This contract has been awarded. Browse open opportunities
Time Left to Bid
Awarded
AwardedHealthcare & MedicalFederal
Basic information
- Reference number
- 75A50126C00004
- Issuing organization
- Department of Health and Human Services · Find award history →
- Government level
- Federal
- Solicitation type
- Healthcare & Medical
- Title
- LATE-STAGE DEVELOPMENT, FDA MARKETING AUTHORIZATION, PROCUREMENT, AND STOCKPILE OF ANTIBIOTICS FOR THE TREATMENT OF DRUG-RESISTANT SECONDARY BACTERIAL INFECTIONS AND/OR THE TREATMENT OR PEP OF INFECTIONS CAUSED BY BIOTHREAT PATHOGENS.
- Source
- usaspending
- Source ID
- CONT_AWD_75A50126C00004_7505_-NONE-_-NONE-
Details
- Location
- NJ, United States
Description
LATE-STAGE DEVELOPMENT, FDA MARKETING AUTHORIZATION, PROCUREMENT, AND STOCKPILE OF ANTIBIOTICS FOR THE TREATMENT OF DRUG-RESISTANT SECONDARY BACTERIAL INFECTIONS AND/OR THE TREATMENT OR PEP OF INFECTIONS CAUSED BY BIOTHREAT PATHOGENS. Awarded to: SHIONOGI INC Sub-agency: Office of Assistant Secretary for Preparedness and Response Contract type: DEFINITIVE CONTRACT
Dates
- Publication
- 2026/04/06 12:00:00 AM UTC
- Closing date
- 2036/03/10 12:00:00 AM UTC
Estimated value
$156.1M USD
Classification
Normalized category
Healthcare & Medical